Market News AIOpen the app

Bristol Myers Squibb and Evotec got the FDA's okay for their second drug together.

TrialRead the original at investingnews.com
Good for BMY

Bristol Myers Squibb received FDA acceptance for a second drug-testing application with Evotec. The candidate is not planned to start an early human trial until 2027, but this advances another drug program.

BMY · Bristol Myers Squibb

AI read · Good for BMY

The AI's read

That gives BMY another treatment to test, and its partner has already moved one candidate into an early human trial. The new candidate is not expected to begin its first human trial until 2027, and no test results are reported.

Get alerts for BMY

Follow Bristol Myers Squibb (BMY) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for BMY
Free on the App Store and Google Play, or on the web.